이상반응 보고
| VAERS ID | 1533701 |
|---|---|
| 성별 | 남성 |
| 나이 | |
| 주 코드 | FR |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | EX6537 |
| 예방접종 횟수 | 2 |
| 접종일 | 2021-05-05 |
| 발병일 | 2021-05-01 |
| 상태 | 중증 사망 |
증상
- 호흡곤란(Dyspnoea)
- 폐 장애(Lung disorder)
- 혈전증(Thrombosis)
- 폐 고혈압(Pulmonary hypertension)
- 우심실 비대(Right ventricular hypertrophy)
- 폐포 출혈(Pulmonary alveolar haemorrhage)
이환 중 질병
지병
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
After II dose - heavy dyspnea; pulmonary hypertension; right ventricular hypertrophy; focal blood vessel thrombosis; intra-alveolic hemorrhages; hypertrophy of smooth muscle of lungs; This is a spontaneous report from a contactable consumer downloaded from the Regulatory Authority-WEB, regulatory authority number LT-SMCA-4213.
A 63-year-old male patient received bnt162b2 (COMIRNATY), second single dose via an unspecified route of administration on 05May2021 (Batch/Lot Number: EX6537) for covid-19 immunisation.
The patient previously received first single dose of bnt162b2 (batch# EW9127) on 14Apr2021 and experienced dyspnea on15Apr2021, which was worsening.
The patient's medical history and concomitant medications were not reported.
After the second dose, the patient experienced heavy dyspnea and lack of air, and died on 06May2021 in less than 24 hours after vaccination.
Autopsy performed included morphological test in May2021 and found pulmonary hypertension, right ventricular hypertrophy, hypertrophy of smooth muscle of lungs, focal blood vessel thrombosis with intra-alveolic hemorrhages.
No follow-up attempts possible.
No further information expected.
; Reported Cause(s) of Death: After II dose - heavy dyspnea; Autopsy-determined Cause(s) of Death: pulmonary hypertension; right ventricular hypertrophy; focal blood vessel thrombosis; intra-alveolic hemorrhages; hypertrophy of smooth muscle of lungs